These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
580 related items for PubMed ID: 26453168
1. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. Abouelmagd SA, Ku YJ, Yeo Y. J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168 [Abstract] [Full Text] [Related]
2. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK. Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614 [Abstract] [Full Text] [Related]
3. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S, Sahoo SK. Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969 [Abstract] [Full Text] [Related]
4. [Preparation and drug release property of paclitaxel nanoparticles]. Wang TW, Wu Y, Li MJ, Gao HX. Zhong Yao Cai; 2009 Sep 30; 32(9):1447-9. PubMed ID: 20034226 [Abstract] [Full Text] [Related]
5. Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. Al-Nemrawi NK, Alshraiedeh NH, Zayed AL, Altaani BM. Pharmaceuticals (Basel); 2018 Mar 08; 11(1):. PubMed ID: 29517998 [Abstract] [Full Text] [Related]
6. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Amoozgar Z, Park J, Lin Q, Yeo Y. Mol Pharm; 2012 May 07; 9(5):1262-70. PubMed ID: 22489704 [Abstract] [Full Text] [Related]
10. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Gullotti E, Park J, Yeo Y. Pharm Res; 2013 Aug 07; 30(8):1956-67. PubMed ID: 23609560 [Abstract] [Full Text] [Related]
11. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification. Zhang S, Tang C, Yin C. Drug Deliv; 2015 Feb 07; 22(2):182-90. PubMed ID: 24215373 [Abstract] [Full Text] [Related]
12. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells. Mattu C, Pabari RM, Boffito M, Sartori S, Ciardelli G, Ramtoola Z. Eur J Pharm Biopharm; 2013 Nov 07; 85(3 Pt A):463-72. PubMed ID: 23916461 [Abstract] [Full Text] [Related]
13. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y. J Control Release; 2017 Dec 28; 268():407-415. PubMed ID: 29111150 [Abstract] [Full Text] [Related]
14. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B. Drug Des Devel Ther; 2015 Dec 28; 9():2705-19. PubMed ID: 26045659 [Abstract] [Full Text] [Related]
15. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors. Wang Y, Li Q, Zhou JE, Tan J, Li M, Xu N, Qu F, Chen J, Li J, Wang J, Liang Z, Yu L, Wang Y, Yan Z. Pharm Res; 2021 Apr 28; 38(4):669-680. PubMed ID: 33796952 [Abstract] [Full Text] [Related]
16. Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release. Tada DB, Singh S, Nagesha D, Jost E, Levy CO, Gultepe E, Cormack R, Makrigiorgos GM, Sridhar S. Pharm Res; 2010 Aug 28; 27(8):1738-45. PubMed ID: 20521086 [Abstract] [Full Text] [Related]